Related Experiment Videos
Composite graft survival. An auricular amputation model
D E Henrich1, T C Logan, R S Lewis
1Division of Otolaryngology Head and Neck Surgery, University of North Carolina, Chapel Hill, USA.
Archives of Otolaryngology--Head & Neck Surgery
|October 1, 1995
Summary
Corticosteroids significantly improved composite graft survival in a rabbit ear reimplantation model. Basic fibroblast growth factor did not show a significant effect on graft survival rates.
Area of Science:
- Regenerative Medicine
- Surgical Innovation
- Tissue Engineering
Background:
- Composite graft survival is crucial for reconstructive surgery.
- Enhancing neovascularization is key to successful graft integration.
- Pharmacological interventions are explored to improve graft outcomes.
Purpose of the Study:
- To evaluate the efficacy of corticosteroids and fibroblast growth factor in enhancing composite graft survival.
- To investigate the role of neovascularization in graft survival.
- To establish a rabbit model for studying composite graft reimplantation.
Main Methods:
- Prospective, randomized, blinded, placebo-controlled animal study.
- Composite auricular grafts were created and reimplanted in rabbits.
- Treatment groups included corticosteroids, fibroblast growth factor, or delayed reimplantation with corticosteroids.
Main Results:
- Corticosteroids significantly increased composite graft survival rates (P < .003).
- Delayed reimplantation combined with corticosteroids also significantly improved survival (P < .006).
- Basic fibroblast growth factor did not yield a significant difference in graft survival compared to controls.
Conclusions:
- Corticosteroids are effective in enhancing composite graft survival.
- Neovascularization plays a significant role in the viability of composite grafts.
- This study provides evidence for the clinical utility of corticosteroids in improving graft success.